Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NxStage Medical Inc (NASDAQ:NXTM)

29.25
Delayed Data
As of 3:59pm ET
 +0.01 / +0.03%
Today’s Change
20.45
Today|||52-Week Range
30.80
+11.60%
Year-to-Date
NxStage Medical Partners Dialyze Direct for On-Site Dialysis
Aug 14 / Zacks.com - Paid Partner Content
Fresenius Medical Inks $2B Deal to Take Over NxStage Medical
Aug 09 / Zacks.com - Paid Partner Content
Foreign Stock Roundup: Novo Nordisk, GOL Linhas Beat on Earnings
Aug 14 / Zacks.com - Paid Partner Content
Company News For August 08, 2017
Aug 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close29.24
Today’s open29.21
Day’s range29.18 - 29.34
Volume2,297,868
Average volume (3 months)1,099,958
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+70.83%
Earnings growth (this year)+51.02%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+9.00%
P/E ratioNM
Price/Sales4.62
Price/Book9.43

Competitors

 Today’s
change
Today’s
% change
INGNInogen Inc+0.87+0.93%
HYHHalyard Health Inc+0.13+0.31%
MMSIMerit Medical System...-0.10-0.24%
MDXGMiMedx Group Inc+0.41+2.55%
Data as of 4:02pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.00
Annual revenue (last year)$366.4M
Annual profit (last year)-$4.8M
Net profit margin-1.30%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Jeffrey H. Burbank
President
Joseph E. Turk
Corporate headquarters
Lawrence, Massachusetts

Forecasts